Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
---|---|
Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
ClinicalTrials.gov Identifier: | NCT00067678 |
Diabetic nephropathy is a frequent cause of end-stage renal disease. Reduction of dietary protein has been used to slow down renal disease progression, but patients are often unwilling to make these dietary changes. Other research suggests that changing the quality of dietary protein may be as effective as reducing the total amount of ingested protein. This study hopes to show that soy protein, a plant protein relatively high in essential amino acids and with high nutritional value, maye be beneficial to Type I diabetic patients with incipient renal disease.
Condition | Intervention | Phase |
---|---|---|
Diabetic Nephropathy Diabetes Mellitus |
Drug: soy protein |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Soy Protein in Early Diabetic Nephropathy |
Ages Eligible for Study: | 18 Years to 40 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
Study ID Numbers: | R21 AT000323-01 |
Study First Received: | August 25, 2003 |
Last Updated: | August 16, 2006 |
ClinicalTrials.gov Identifier: | NCT00067678 |
Health Authority: | United States: Federal Government |
diabetic nephropathy nephropathy diabetes |
diabetes mellitus type I diabetes soy protein |
Metabolic Diseases Diabetic Nephropathies Urologic Diseases Diabetes Mellitus, Type 1 Diabetes mellitus type 1 Diabetes Mellitus |
Endocrine System Diseases Endocrinopathy Kidney Diseases Metabolic disorder Glucose Metabolism Disorders Diabetes Complications |